title: [Current therapeutic approach to diabetic macular edema refractory to laser coagulation].
abstract: The paper presents the evolution of a diabetic patient with CSME resistant to laser treatment. The intravitreal injection of Triamcinolone Acetonid represented a very efficient therapeutic solution the visual accuity improving for a period of 7-9 months.
authors.affiliation: Clinica de Oftalmologie Craiova.
authors.forename: Livia
authors.initials: L
authors.lastname: Davidescu
authors.forename: F
authors.initials: F
authors.lastname: Baltă
authors.forename: Carmen
authors.initials: C
authors.lastname: Mocanu
authors.forename: Cristina Ramona
authors.initials: CR
authors.lastname: Puşcaşu
authors.forename: A
authors.initials: A
authors.lastname: Olaru
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D056965:Injections, Intraocular; D017075:Laser Coagulation; D008269:Macular Edema / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects*
chemical_list: D000893:Anti-Inflammatory Agents; D014222:Triamcinolone Acetonide